|Wed, 25 Dec 2002 10:27:11 +1300
Ryanrite and others
What do you know about the company Ryanrite? IMHO it is not yet a good company.
The success of VCR depends ultimately on the success, or otherwise, of the human implant trials due to start early 2003.
The price of MMD fluctuated widely. It got to $1.08 a while back before retracing to mid .60c range. It has now made another run. There have been good and bad times with this stock. The share placement at .80c was frowned on by many when the price of the stock at that time was about .90c. That possibly led to the retracement.
VCR has got two 'income' channels. The ventrassist is not earning for the company and won't until the trials end. Their other medical products are doing okay.
If you are going to buy this stock, watch it very closely. If the trials don't go well, the drop in PTD may look mild compared with what could happen here. Nevertheless, the ventrassist has worked in sheep. I expect the trials to succeed. If so, the stock could surge well past $2. If not, .30c is likely. Gerry picks some good stocks. He also has picked some others that have not gone so well.